S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.30%) $2 349.60
Silver
(-0.47%) $27.23
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Realtime updates for MaxCyte Inc [MXCT.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated26 Apr 2024 @ 11:20

0.00% £ 295.00

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:20):

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering...

Stats
Today's Volume 10 668.00
Average Volume 28 348.00
Market Cap 307.18M
EPS £0 ( 2024-03-11 )
Next earnings date ( £0 ) 2024-05-06
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -9.83
ATR14 £0 (0.00%)

MaxCyte Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MaxCyte Inc Financials

Annual 2023
Revenue: £41.29M
Gross Profit: £36.55M (88.51 %)
EPS: £-0.370
FY 2023
Revenue: £41.29M
Gross Profit: £36.55M (88.51 %)
EPS: £-0.370
FY 2022
Revenue: £44.26M
Gross Profit: £39.16M (88.48 %)
EPS: £-0.190
FY 2021
Revenue: £33.89M
Gross Profit: £30.25M (89.24 %)
EPS: £-0.210

Financial Reports:

No articles found.

MaxCyte Inc

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators